Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease

Autor: Harrison N. Jones, Anita K. Simonds, Emilia Barrot Cortés, Katalin Várdi, Matthias Boentert, Uwe Mellies, Hélène Prigent, Marco Confalonieri, Stephan Wenninger
Přispěvatelé: Boentert, Matthia, Prigent, Hélène, Várdi, Katalin, Jones, Harrison N., Mellies, Uwe, Simonds, Anita K., Wenninger, Stephan, Barrot Cortés, Emilia, Confalonieri, Marco
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Chemistry
Multidisciplinary

medicine.medical_treatment
Neuromuscular disorder
Medizin
Review
neuromuscular disorders
lcsh:Chemistry
Mechanical ventilation
0302 clinical medicine
Respiratory muscle weakne
Surveys and Questionnaires
OBSTRUCTIVE SLEEP-APNEA
Glycogen storage disease type II
FAILURE
PREDICTORS
lcsh:QH301-705.5
Spectroscopy
Respiratory Function Test
Muscle Weakness
Glycogen Storage Disease Type II
Cough assistance
Pompe disease
General Medicine
Enzyme replacement therapy
Respiratory Muscles
Computer Science Applications
Respiratory Function Tests
LUNG-FUNCTION
Chemistry
Physical Sciences
medicine.symptom
Respiratory Insufficiency
Life Sciences & Biomedicine
Human
Muscle Weakne
Adult
Biochemistry & Molecular Biology
medicine.medical_specialty
respiratory muscle weakness
Proximal muscle weakness
POLYSOMNOGRAPHIC FINDINGS
0699 Other Biological Sciences
mechanical ventilation
Catalysis
DUCHENNE MUSCULAR-DYSTROPHY
Inorganic Chemistry
03 medical and health sciences
Intensive care
0399 Other Chemical Sciences
medicine
Respiratory muscle
Humans
cough assistance
Physical and Theoretical Chemistry
Myopathy
Intensive care medicine
Molecular Biology
NEUROMUSCULAR-JUNCTION
AIRWAY CLEARANCE
0604 Genetics
Science & Technology
Chemical Physics
business.industry
Organic Chemistry
PULMONARY-FUNCTION
Muscle weakness
Infant
ADULTS
medicine.disease
Neuromuscular disorders
Respiratory muscle weakness
lcsh:Biology (General)
lcsh:QD1-999
030228 respiratory system
Physical therapy
business
030217 neurology & neurosurgery
Zdroj: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 17, Iss 10, p 1735 (2016)
Popis: Pompe disease is an autosomal-recessive lysosomal storage disorder characterized by progressive myopathy with proximal muscle weakness, respiratory muscle dysfunction, and cardiomyopathy (in infants only). In patients with juvenile or adult disease onset, respiratory muscle weakness may decline more rapidly than overall neurological disability. Sleep-disordered breathing, daytime hypercapnia, and the need for nocturnal ventilation eventually evolve in most patients. Additionally, respiratory muscle weakness leads to decreased cough and impaired airway clearance, increasing the risk of acute respiratory illness. Progressive respiratory muscle weakness is a major cause of morbidity and mortality in late-onset Pompe disease even if enzyme replacement therapy has been established. Practical knowledge of how to detect, monitor and manage respiratory muscle involvement is crucial for optimal patient care. A multidisciplinary approach combining the expertise of neurologists, pulmonologists, and intensive care specialists is needed. Based on the authors' own experience in over 200 patients, this article conveys expert recommendations for the diagnosis and management of respiratory muscle weakness and its sequelae in late-onset Pompe disease. OA gold
Databáze: OpenAIRE